Navigation Links
Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
Date:9/18/2009

GUATEMALA CITY, Sept. 18 /PRNewswire-FirstCall/ -- Cancer patients in Guatemala and across Central America now have access to advanced radiotherapy treatments, including intensity-modulated radiotherapy (IMRT) with RapidArc(R) technology. Hope International Centro de Radioterapia has become the first treatment center in Latin America to install the fast new treatment capability from Varian Medical Systems (NYSE: VAR).

With RapidArc, Hope International Centro de Radioterapia, a new privately-funded clinic, can provide more advanced care to a greater number of patients than would be possible with conventional technology. It is equipped with state-of-the-art technology for delivering the full spectrum of image-guided cancer treatments.

"We are able to offer IMRT, which targets cancer cells while minimizing damage to surrounding tissues and organs," says Luis A. Linares, MD, Medical Director. "With RapidArc, we have the potential to further enhance our precision by completing many of these treatments more quickly, which can reduce the extent of patient motion during treatment. All treatments will be delivered using a high resolution multileaf collimator to shape the treatment beam so that it matches the shape and size of the tumor from every angle."

The new treatment technology was unveiled on September 10, 2009, at an inauguration attended by many local dignitaries, including Alvaro Arzu, mayor of Guatemala City; cabinet-level government officials; medical specialists from across the region; and prominent leaders from the private sector.

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided IMRT two to eight t
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Houston Heart Surgeon Elected Vice President of Guatemala
2. Guatemalas Fundacion Ayudame a Vivir Fundraising Campaign Raises More Than $2.6 Million
3. Prosecutors Dismal Record Showing Improvement in Guatemala
4. Guatemalas Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation
5. Hard to Treat Diseases (HTDS) enters Guatemala market
6. Operation Walk Pittsburgh Performs Over 63 Free Surgeries in Guatemala
7. New treatment effective in counteracting cocaine-induced symptoms
8. New treatment boosts muscle function in myasthenia gravis
9. Broad-based group of physicians calls for improvement in stroke treatment
10. Cranberry Could Juice Up Ovarian Cancer Treatment
11. Non-medicinal treatment touted for pre-schoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , SOUTH SAN FRANCISCO, Calif., July 10 ... the International Society on Thrombosis and Haemostasis (ISTH) XII ... drug elinogrel, a P2Y(12) ADP receptor antagonist currently in ... inhibitor anticoagulant antidote in pre-clinical development, as well as ...
... adulthood, study shows , THURSDAY, July 9 (HealthDay News) ... can persist into adulthood, U.S. researchers report. , Young ... than 5.5 pounds at birth) have an increased risk ... findings suggest that not only are [low birth weight] ...
... ... are now available in Canada from Electro Sonic. , ... Chatsworth, CA (PRWEB) July 10, 2009 -- NMB Technologies Corporation, a ... have reached a distribution agreement. Under the terms of this agreement, Electro Sonic, ...
... 10 Eli Lilly and Company (NYSE: ... 35th year of support for the Indiana Black Expo (IBE) Summer Celebration, ... presence at the IN Shape Indiana Black and Minority ... in these uncertain economic times. , , An example of this ...
... Growing in the number of those afflicted, Alzheimer,s takes ... caregivers, "Alzheimer,s Days Gone By: For Those Caring For Their ... Lueckenotte weaves a heartfelt mix of personal experience and sound ... of loved ones during the descent into dementia. , ...
... (Nasdaq: QGLY ) , ... Rosenbloom has resumed providing services to the Company,s Quigley Pharma subsidiary. ... late May, 2009. , , Ted Karkus, Chairman and interim ... Rosenbloom again serving our Pharma subsidiary and helping in the development ...
Cached Medicine News:Health News:Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 2Health News:Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 3Health News:Respiratory Issues Linger for Smallest Babies 2Health News:NMB Expands in Canada 2Health News:Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo 2Health News:Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo 3Health News:Insightful Handbook for Alzheimer's Caregivers 2Health News:Insightful Handbook for Alzheimer's Caregivers 3Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 2Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 3
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 ... plc (NASDAQ: ENDP ) (TSX: ENL), and ... announced today that they have submitted a New Drug ... U.S. Food and Drug Administration (FDA).  Buprenorphine HCl Buccal ... severe enough to require daily, around-the-clock, long-term opioid treatment ...
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) has ... Glucose Market" report to their offering. ... insight focuses on the developments in the self-monitoring blood ... . Reimbursement analysis and the effects of competitive bidding ... 73 SMBG meters have been performed, based on the ...
(Date:12/22/2014)... and STOCKHOLM , Dec. ... (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced that ... of the European Medicines Agency (EMA) has adopted a ... histolyticum) for the treatment of adult men with Peyronie,s ... at least 30 degrees at the start of therapy. ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... 2007 /PRNewswire/ -- Mersana, a,cancer therapeutics company, announced ... product candidate, XMT-1001, will,be presented in two posters ... of Cancer Research (AACR) taking place April,14-18th in ... can be,viewed online at the AACR website at ...
... 13, 2007 - Biogen Idec Inc.,(NASDAQ: BIIB) ... the,Academy of Managed Care Pharmacy's (AMCP) 2007 ... a cost-effective therapy in,multiple sclerosis (MS) when ... comprehensive analysis of medical and pharmacy,costs, the ...
Cached Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 3
These flexible stone retrieval devices are reusable, 3 Fr in diameter, with a working length of either 60 cm or 115 cm...
... The Brasseler USA™ MicroLine™ Small Bone ... of operation while performing under the ... powered system developed for small bone ... Drill, Sagittal Saw (Extended Length Available), ...
... Drill, with hand throttle, 30,000 ... Built-in medium bur guard included, ... bur guards are also available. ... hand throttle (#1940) for use ...
... Electric Micro Drill, without hand ... of torque. Built-in medium bur ... extra-long (#1100-006) bur guards are ... with foot throttle (#6401-000), can ...
Medicine Products: